The Optimizing Women’s Health Conditions in Canada from Pfizer supports Quality Improvement projects focused on optimizing women’s health conditions, including uterine fibroids, endometriosis, and/or contraception, in Canada. Applications are open to medical, nursing, allied health, and/or pharmacy professional schools; healthcare institutions (both large and small); professional associations and medical societies; medical education companies; and other entities with a mission related to healthcare professional education and/or healthcare improvement in Canada.
The grant provides 30,000 CAD (including 28% institutional overheads).
Applications are due on July 19, 2023.
Menu
